Cormorant Private Healthcare Fund III LP (CIK 1817320) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-10-01). Recent activity: Sell MLTX (70,748 shares), Sell MLTX (232,460 shares), Sell MLTX (3.4M shares), Sell MLTX (2.8M shares), Sell MLTX (5,827 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 70,748 | $663,616 |
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 232,460 | $2.0M |
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 3.4M | $25.7M |
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 2.8M | $18.5M |
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 5,827 | $40,556 |
| 2025-05-19 | OnKure Therapeutics, Inc. (OKUR) | Insider | Sell | 1.8M | $3.4M |
| 2025-05-14 | OnKure Therapeutics, Inc. (OKUR) | Insider | Sell | 24,300 | $48,357 |
Source: SEC Form 4 filings · as of 2025-10-01